Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity
作者:Maria G. Katselou、Alexios N. Matralis、Angeliki P. Kourounakis
DOI:10.1016/j.ejmech.2017.06.042
日期:2017.9
present the design, synthesis and pharmacological evaluation of novel dual-acting molecules as a therapeutic approach for atherosclerosis. Analogues 1–10 were rationally designed through structural modifications of their parent compounds (A-E) in order for structure-activity relationship studies to be carried out. Most compounds showed a significant inhibition against Squalene Synthase activity exhibiting
对于多因素和复杂疾病的治疗,与仅对单个靶标具有高特异性的化合物相比,作用于多个靶标的化合物通常具有更高的疗效,这一点已变得越来越明显。在先前研究证明吗啉和1,4-苯并(x / thi)嗪衍生物(AE)具有重要的抗氧化和降血脂作用的基础上,我们在此介绍新型双作用分子作为药物的设计,合成和药理学评价。动脉粥样硬化的治疗方法。类似物1–10是通过对其母体化合物(AE),以便进行结构-活性关系研究。大多数化合物显示出对角鲨烯合酶活性的显着抑制作用,同时显示出非常有效的多峰抗氧化剂(抗脂质过氧化和自由基清除剂)作用,从而使2-芳基-1,4-苯并(x / thia)zin-2-ol支架是用于设计有效抗氧化剂的出色药效基团。最后,尽管保留了(抗高胆固醇血症)活性甚至改善了(抗高血脂血症)活性,但用其各自的1,4-苯并噻嗪(化合物4)代替了铅化合物D的八氢-1,4-苯并恶嗪部分。保留D的抗糖尿病作用。